X-ray Structure of Human ACMSD with TES-1025
TES Pharma announces the publication of a Frontiers in Molecular Biosciences, section Structural Biology paper “ Structural basis of human dimeric…
Prof. Roberto Pellicciari Recipient of the EFMC Honorary Fellow Award
TES Pharma is pleased to congratulate Prof Roberto Pellicciari as one of the first recipients of the EFMC Honorary Fellow…
POR FESR 2014-2020, Asse I, Azione 1.1.1. – Avviso Ricerca 2020 – Regione Umbria
“Ricerca e Sviluppo di Modulatori del NAD+ per il Trattamento della Disfunzione Epato-Renale in Pazienti COVID-19” Progetto finanziato dalla Regione Umbria nel quadro…
POR FESR 2014-2020. Asse I Azione 1.1.1. – Regione Umbria
“Modulazione farmacologica dell’omeostasi della Nicotinamide Dinucleotide (NAD+) come approccio terapeutico innovativo per il trattamento dell’insulto renale acuto” Progetto finanziato dalla Regione…
Mitochondrial Dysfunction is a Key Driver of Acute Kidney Injury Pathophysiology
As highlighted in Nature Reviews Nephrology by Prof. John Kellum (Center for Critical Care Nephrology, Univ. of Pittsburgh) in his…
Targeting NAD+ Synthesis via inhibition of ACMSD to prevent NAFLD and AKI
Publishing in Nature, scientists lead Johan Auwerx at EPFL (Lausanne) and Roberto Pellicciari at TES Pharma have found a new…
De novo NAD+ synthesis enhances mitochondrial function and improves health
TES Pharma announces the publication of a Nature paper “De novo NAD+ synthesis enhances mitochondrial function and improves health” (DOI: 10.1038/s41586-018-0645-6)…
POR FESR 2014-2020 Regione Umbria
Progetto finanziato dalla Regione Umbria nel quadro del “Bando a sostegno dei progetti complessi di ricerca & sviluppo - POR FESR 2014-2020”.…
α-Amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD) Inhibitors as Novel Modulators of NAD+ Biosynthesis
TES Pharma announces the publication of a Journal of Medicinal Chemistry paper “α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of…
Umbria ERDF Project
TES announces the successful awarding of a European Regional Development Fund, Umbria project, "Integrated platform for innovative drug research and…